Rodeo Therapeutics' Series A Round

Rodeo Therapeutics raised a round of funding on July 25, 2017.

Rodeo Therapeutics is a preclinical-stage biotech company focused on first in class small molecule modulators of prostaglandin biology for enhancing tissue repair and regeneration.…

Articles about Rodeo Therapeutics' Series A Round: